Argos Therapeutics, Inc. (ARGS) Posts Q1 Loss of $1.05/Share

Argos Therapeutics, Inc. (NASDAQ: ARGS) reported Q1 EPS of ($1.05), $0.59 worse than the analyst estimate of ($0.46). Revenue for the quarter came in at $798.8 thousand versus the consensus estimate of $1.26 million.

For earnings history and earnings-related data on Argos Therapeutics, Inc. (ARGS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Movano (MOVE) Misses Q2 EPS by 195c
• Diana Shipping withdraws bid to acquire Genco Shipping